Bathe, O. F. Open Access Govt July 2026. Published on 2026-06-03 Abstract Molecular risk testing: A smarter system for thyroid cancer care. Oliver Bathe, Professor of Surgery and Oncology at…
Introduction Papillary thyroid cancer is the most common type of thyroid cancer, and its incidence is increasing by approximately 6% every year. For most patients, the prognosis is good. But…
Introduction When most people think about cancer testing, they think about looking for something specific. A mutation, a protein, a genetic change. The tests we explored in our previous articles…
Introduction In our previous article, we explored the different categories of biomarkers used in cancer care, from those that signal disease risk to those that help monitor a patient's response…
Introduction In our previous article, we explored the different types of biomarkers and why they matter in cancer care. Biomarkers can signal disease risk, confirm a diagnosis, predict how a…
Introduction In our previous blog post, we explored some of the early breakthroughs that reshaped cancer treatment. Precision oncology is an approach to cancer treatment that is tailored to the…
Introduction Precision oncology began gaining traction in the late 1990s and has since reshaped how we understand and treat cancer. Rather than classifying tumors solely by where they arise in…